Skip to content

The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery

The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery, a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03650868
Enrollment
40
Registered
2018-08-29
Start date
2018-09-01
Completion date
2019-02-26
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Seroma

Keywords

Thoracal Paravertebral Block, Breast Surgery, Seroma Reduction

Brief summary

Thoracal paravertebral block (TPVB) is a commonly prefferred regional anesthesia technique to provide postoperative analgesia. In addition, the successful use of TPVB is reported for some seroma related pain cases. Postoperative analgesia in breast surgery is a difficult and overworked issue due to etensive surgery and complex innervation of the breast and in addition to this complex mechanisms, seroma accumulation has a negative effect for patients postoperatively. With this study, the investigators aimed to study the effect of TPVB on seroma reduction for breast cancer surgery.

Interventions

PROCEDUREThoracal paravertebral block

Thoracal paravertebral block will be performed before the surgery to the TPVB group.

Sponsors

Kocaeli University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-70 years of agge * ASA I-II * Undergoing elective breast cancer surgery

Exclusion criteria

* obesity (body mass index \>35 kg/m2) * infection of the skin at the site of needle puncture area * patients with known allergies to any of the study drugs * coagulopathy

Design outcomes

Primary

MeasureTime frameDescription
Seroma quantitiy24 hour postoperatively.Seroma quantitiy of all patients will be recorded after 24 hour postoperatively.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026